BICO Group Overview

  • Status
  • Public

  • Employees
  • 554

Employees

  • Stock Symbol
  • BICO

Stock Symbol

  • Investments
  • 16

  • Share Price
  • $1.56
  • (As of Thursday Closing)

BICO Group General Information

Description

BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.

Contact Information

Website
www.bico.com
Formerly Known As
Cellink
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Grafiska vägen 2B
  • 412 63 Gothenburg
  • Sweden
+46 020-10
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Stock Exchange
STO
Vertical(s)
Corporate Office
  • Grafiska vägen 2B
  • 412 63 Gothenburg
  • Sweden
+46 020-10

BICO Group Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BICO Group Stock Performance

As of 19-Nov-2026, BICO Group’s stock price is $1.56. Its current market cap is $110M with 70.6M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.56 $1.61 $1.33 - $2.58 $110M 70.6M 406K -$0.68

BICO Group Financials Summary

As of 30-Sep-2026, BICO Group has a trailing 12-month revenue of $168M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 160,178 168,074 320,617 536,610
Revenue 168,416 152,391 163,314 189,141
EBITDA 12,473 (132,981) 26,693 14,837
Net Income (47,699) (110,833) (520) (110,329)
Total Assets 257,859 401,721 496,959 606,347
Total Debt 69,757 139,840 159,822 195,939
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BICO Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BICO Group‘s full profile, request access.

Request a free trial

BICO Group Patents

BICO Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220349007-A1 Method of culturing and analyzing at least one cell in a microchamber configured to allow for optical inspection of the at least one cell, a device for use in the method, a system and a computer program for performing one or more of the steps of the method Inactive 29-Apr-2021
US-20240157629-A1 3d bioprinter with continuous workflow capability Inactive 12-Mar-2021
WO-2022180565-A1 Silk fibroin and related use for 3d bioprinting Inactive 25-Feb-2021
US-20240131220-A1 Silk fibroin bioinks and related use for 3d bioprinting Pending 25-Feb-2021
US-20240226377-A9 Silk fibroin bioinks and related use for 3d bioprinting Pending 25-Feb-2021 A61L27/26
To view BICO Group’s complete patent history, request access »

BICO Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BICO Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BICO Group‘s full profile, request access.

Request a free trial

BICO Group Investments & Acquisitions (16)

BICO Group’s most recent deal was a Merger/Acquisition with Allegro 3D for . The deal was made on 05-May-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Allegro 3D 05-May-2022 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Biosero 16-Dec-2021 Merger/Acquisition Business/Productivity Software
QInstruments 15-Oct-2021 Merger/Acquisition Other Devices and Supplies
Nanochon 01-Oct-2021 Seed Round Therapeutic Devices
Hurel 15-Sep-2021 Merger/Acquisition Discovery Tools (Healthcare)
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

BICO Group ESG

Risk Overview

Risk Rating

Updated November, 30, 2024

18.59 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Pharmaceuticals

Industry

of 908

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 68

Rank

Percentile

To view BICO Group’s complete esg history, request access »

BICO Group Exits (4)

BICO Group’s most recent exit was on 20-May-2021 from Visikol. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Visikol 20-May-2021 Completed
MatTek 22-Mar-2021 Completed
Ginolis 01-Mar-2021 Completed
Cytena Bioprocess Solutions 29-Dec-2020 Early Stage VC Completed
  • 2 buyers
To view BICO Group’s complete exits history, request access »

BICO Group Affiliates

Subsidiaries (9)

Name Industry Location Year Founded
Bico International Goteborg, Sweden 2018
Dispendix Stuttgart, Germany 2016
Cytena Freiburg, Germany 2014
Discover Echo San Diego, CA 2013
Ginolis Oulu, Finland 2010
You’re viewing 5 of 9 affiliates. Get the full list.  »

BICO Group FAQs

  • Where is BICO Group headquartered?

    BICO Group is headquartered in Gothenburg, Sweden.

  • What is the size of BICO Group?

    BICO Group has 554 total employees.

  • What industry is BICO Group in?

    BICO Group’s primary industry is Biotechnology.

  • Is BICO Group a private or public company?

    BICO Group is a Public company.

  • What is BICO Group’s stock symbol?

    The ticker symbol for BICO Group is BICO.

  • What is the current stock price of BICO Group?

    As of 19-Nov-2026 the stock price of BICO Group is $1.56.

  • What is the current market cap of BICO Group?

    The current market capitalization of BICO Group is $110M.

  • What is BICO Group’s current revenue?

    The trailing twelve month revenue for BICO Group is $168M.

  • What is BICO Group’s annual earnings per share (EPS)?

    BICO Group’s EPS for 12 months was -$0.68.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process